Volume 14 Supplement 3
Abstracts from the 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014)
Meeting abstracts
Edited by Suniti Solomon, Sunil S Solomon, P Balakrishnan, KG Murugavel, S Saravanan, Syed H Iqbal and R Vignesh
The publication charges for this supplement were funded by the Indian Council of Medical Research (ICMR), Department of Biotechnology (DBT), Department of Science and Technology (DST) and Council of Scientific and Industrial Research (CSIR). The Supplement Editors declare that they have no competing interests.
2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014). Go to conference site.
Chennai, India30 January - 1 February 2014
Page 3 of 4
-
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P72
-
The microbiological profile of nosocomial infections in an intensive care unit
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P73 -
A pilot study of varicella zoster infection among patients with fever and rash in a tertiary care centre
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P74 -
Profile of opportunistic infections in AIDS patients in relation to CD4 count in a tertiary care hospital
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P75 -
Effect of anti retroviral therapy on mucocutaneous manifestations among HIV infected patients in a tertiary care centre in India
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P76 -
Prevalence of cryptococcal meningitis and lymphadenitis among PLHA
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P77 -
Exploring the protein-protein interface of integrin-galectin complex for drug development against HIV infection- a bioinformatics study
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P78 -
Vasculitis with lichenoid eruptions in Hepatitis B infection – case report
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P79 -
Comparison of plasma and salivary HIV loads determined via a coupling of the Abbott HIV detection system with the DNA Genotek OMNIgeneâ„¢ DISCOVER (OM-505) kits
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P80 -
Functional characterization of HIV-1 Tat exon-1 variants from North India and their implications on HIV-1 transactivation and TAR interaction
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P81 -
Knowledge, attitude and practice of HIV/AIDS among employees of a medical line factory in Kamunting, Malaysia
Citation: BMC Infectious Diseases 2014 14(Suppl 3):P82 -
HAART restores the frequency of regulatory T cells (Tregs) among HIV/AIDS patients
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E1 -
Comparative codon usage analysis of HIV-1 and HIV-2 genomes
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E2 -
Computational studies on non-nucleoside analogs of pyrimidine as NNRTIs against HIV-1
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E3 -
Computational modelling, green synthesis and biological activity of arylsulfonilamides as NNRTIs against HIV-1
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E4 -
Tenofovir induced renal damage is associated with activation of NF-κB inflammatory signaling pathway and PARP overactivation
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E5 -
Docking studies of flavonoid derivatives as potent HIV-1 integrase inhibitors
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E6 -
Longer sequence insertions in p6 gag play a role in immune escape in HIV-1 subtype C
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E7 -
Genotypic characterization of HIV-1 C variants in PBMCs and cervicovaginal cells
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E8 -
Genotypic characterization of HIV variants from PBMCs and spermatozoa
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E9 -
Expression of cytokine-mRNA in PBMC of HIV-1 subtype C infected individuals with opportunistic viral infections from South India
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E10 -
Polymorphisms in reverse transcriptase and protease genes of HIV-1 subtype C from Mumbai
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E11 -
Use of multi-primer / multi-gene PCR method for the detection of Mycobacterium tuberculosis among female genital tuberculosis patients in India
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E12 -
Early infant diagnosis: gateway to survival for HIV positive infants
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E13 -
Hybrid BFPSO algorithm based estimation of optimal drug dosage for antiretroviral therapy in HIV-1 infected patients
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E14 -
Design, synthesis and biological evaluation on N- heteroaryl compounds as probable NNRTIs against laboratory adapted strains and the primary isolates of HIV-1
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E15 -
Host factors influencing the activation of tuberculosis in HIV positive individuals with latent TB infection
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E16 -
Reiter’s syndrome as a manifestation of immune reconstitution inflammatory syndrome in an HIV infected individual
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E17 -
N-Heterocyclic analogues as peptide deformylase inhibitors: Molecular modeling, synthesis and antibacterial evaluation
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E18 -
Alphalinolenic acid, a potent inhibitor of fatty acid synthase antimycobacterial agent
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E19 -
Mycobacterium bovis Bacille Calmette-Guerin infection modulates GRK2/3 dependent cytokine secretion
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E20 -
In silco analysis of carboxamide derivatives of piperidine as potential antagonists of CCR5
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E21 -
The PknI and DacB2 double deletion mutant of Mycobacterium tuberculosis leads to alteration of cell morphology and susceptibility to antibiotics
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E22 -
In silico analysis of drug resistance in wild type and mutant HIV-1 subtype d protease
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E23 -
Development of dual inhibitors targeting DprE1 and AHAS for treatment of Mycobacterium tuberculosis infection
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E24 -
Production of cross neutralizing single chain fragment variables (scFv) from HIV-1 infected Indian children
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E25 -
Neuro-psychiatric co morbidity in HIV/AIDS; and effect of alcohol in CD4 count in HIV patients
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E26 -
M. tuberculosis Peptide based Point-of care test for TB
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E27 -
Assessment of oxidative stress parameters in HIV infection
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E28 -
Assessment of the anti-HBV like property of BEHP – a phthalate derivative and its insilico characterization
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E29 -
HbAHP-25, a peptide designed in silico, exhibits potent anti-HIV activity in vitro
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E30 -
HPV associated oral lesions among HIV/AIDS patients - a cross sectional study
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E31 -
Seroprevalence of viral hepatitis in jaundiced pregnant women in a teritiary care hospital
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E32 -
Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis infection in pregnant adolescent women and its association with pregnancy outcomes
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E33 -
Prevalence of HPV in the oral cavity of HIV seropositive Indian women undergoing HAART
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E34 -
Lower genital tract infections during pregnancy and adverse pregnancy outcomes: a hospital based observational cohort study
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E35 -
Surface functionalized nanoparticles of NVP an improved strategy to tackle deadly HIV infection
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E36 -
Biliary tract malignancies in HIV infected persons: a case series
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E37 -
Squamous cell carcinoma of tongue in HIV patients- a report of 3 cases
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E38 -
Lamivudine sensitivity - a case report
Citation: BMC Infectious Diseases 2014 14(Suppl 3):E39
Annual Journal Metrics
-
Citation Impact
3.669 - 2-year Impact Factor (2021)
3.714 - 5-year Impact Factor (2021)
1.448 - SNIP (Source Normalized Impact per Paper)
1.042 - SJR (SCImago Journal Rank)Speed
16 days to first decision for all manuscripts (Median)
42 days to first decision for reviewed manuscripts only (Median)Usage
10,831,430 Downloads (2022)
28,243 Altmetric mentions (2021)
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication